|
WO2011133178A1
|
|
Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
|
|
WO2011133179A1
|
|
Compositions comprising enzyme-cleavable hydromorphone prodrug
|
|
WO2011133151A1
|
|
Compositions comprising enzyme-cleavable phenol-modified opioid prodrugs and inhibitors thereof
|
|
MX2011004095A
|
|
Pharmaceutical compositions with attenuated release of phenolic opioids.
|
|
WO2009140275A1
|
|
Analogs of propofol, preparation thereof and use as anesthetics
|
|
US2010273820A1
|
|
Peripheral Phenolic Opioid Antagonist
|
|
BRPI0811284A2
|
|
Therapeutic compounds
|
|
NZ580752A
|
|
Stereoisomers propofol therapeutic compounds
|
|
NZ580759A
|
|
Stereoisomers propofol therapeutic compounds
|
|
WO2008101187A2
|
|
Pro-drugs of peripheral phenolic opioid antagonists
|
|
AU2007275200A1
|
|
Anesthetic compounds
|
|
CN101528264A
|
|
Controlled release of phenolic opioids
|
|
US2006128676A1
|
|
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain
|
|
WO2006017354A1
|
|
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing disease or pain
|
|
US2006111382A1
|
|
Compositions and methods for treating or preventing pain
|
|
BRPI0511237A
|
|
Compositions and methods for the treatment or prevention of pain
|
